The Latest Breaking News from ELAN

Elanco Animal Health Inc (NYSE:ELAN) has reported a Q1 EPS of $0.36, lower than the $0.37 reported a year ago, surpassing analysts' view of $0.35. Revenue was $1.225 billion, a decrease of 1% YY, slightly above the consensus of $1.22 billion. Pet Health's revenue decreased by 1% and was up 2% when excluding…

Elanco Animal Health (NYSE:ELAN) will host a conference call at 08:00 AM ET on May 9, 2022, to discuss Q1 2022 earnings results. How to Attend Elanco Animal Health (ELAN) Conference Call Follow this link to access the live webcast.

Elanco Animal Health Incorporated (NYSE:ELAN) and Ginkgo Bioworks Holdings Inc (NYSE:DNA) have launched BiomEdit, a microbiome innovation company. BiomEdit will discover, develop and introduce novel probiotics, bioactive molecules, engineered microbial medicines, and microbial monitoring services for animal health. In October last year, Elanco announced its intention to carve out its microbiome platform and pipeline under the leadership…

Given the unprecedented increase in pet ownership since the onset of the COVID-19 pandemic, rising consumer spending on pet food, medications, and other ancillary pet services has driven the pet care industry’s growth. Because high demand is expected to persist going forward, prominent pet stocks IDEXX Laboratories (IDXX) and Elanco…